These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 22308410)

  • 1. Ribosome clearance by FusB-type proteins mediates resistance to the antibiotic fusidic acid.
    Cox G; Thompson GS; Jenkins HT; Peske F; Savelsbergh A; Rodnina MV; Wintermeyer W; Homans SW; Edwards TA; O'Neill AJ
    Proc Natl Acad Sci U S A; 2012 Feb; 109(6):2102-7. PubMed ID: 22308410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure and function of FusB: an elongation factor G-binding fusidic acid resistance protein active in ribosomal translocation and recycling.
    Guo X; Peisker K; Bäckbro K; Chen Y; Koripella RK; Mandava CS; Sanyal S; Selmer M
    Open Biol; 2012 Mar; 2(3):120016. PubMed ID: 22645663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fusidic acid resistance through changes in the dynamics of the drug target.
    Tomlinson JH; Kalverda AP; Calabrese AN
    Proc Natl Acad Sci U S A; 2020 Oct; 117(41):25523-25531. PubMed ID: 32999060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Staphylococcus aureus elongation factor G--structure and analysis of a target for fusidic acid.
    Chen Y; Koripella RK; Sanyal S; Selmer M
    FEBS J; 2010 Sep; 277(18):3789-803. PubMed ID: 20718859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutagenesis mapping of the protein-protein interaction underlying FusB-type fusidic acid resistance.
    Cox G; Edwards TA; O'Neill AJ
    Antimicrob Agents Chemother; 2013 Oct; 57(10):4640-4. PubMed ID: 23836182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of elongation factor-G-mediated fusidic acid resistance and fitness compensation in Staphylococcus aureus.
    Koripella RK; Chen Y; Peisker K; Koh CS; Selmer M; Sanyal S
    J Biol Chem; 2012 Aug; 287(36):30257-67. PubMed ID: 22767604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A target-protection mechanism of antibiotic resistance at atomic resolution: insights into FusB-type fusidic acid resistance.
    Tomlinson JH; Thompson GS; Kalverda AP; Zhuravleva A; O'Neill AJ
    Sci Rep; 2016 Jan; 6():19524. PubMed ID: 26781961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fusidic acid resistance determinants in Staphylococcus aureus clinical isolates.
    Chen HJ; Hung WC; Tseng SP; Tsai JC; Hsueh PR; Teng LJ
    Antimicrob Agents Chemother; 2010 Dec; 54(12):4985-91. PubMed ID: 20855746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structures of the Staphylococcus aureus ribosome inhibited by fusidic acid and fusidic acid cyclopentane.
    González-López A; Larsson DSD; Koripella RK; Cain BN; Chavez MG; Hergenrother PJ; Sanyal S; Selmer M
    Sci Rep; 2024 Jun; 14(1):14253. PubMed ID: 38902339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic determinants of resistance to fusidic acid among clinical bacteremia isolates of Staphylococcus aureus.
    Lannergård J; Norström T; Hughes D
    Antimicrob Agents Chemother; 2009 May; 53(5):2059-65. PubMed ID: 19289529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular basis of fusB-mediated resistance to fusidic acid in Staphylococcus aureus.
    O'Neill AJ; Chopra I
    Mol Microbiol; 2006 Jan; 59(2):664-76. PubMed ID: 16390458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of fusidic acid-resistant Staphylococcus aureus isolates in the community of Casablanca (Morocco).
    Elazhari M; Abu-Quatouseh LF; Elhabchi D; Zerouali K; Dersi N; Saile R; Timinouni M; Becker K
    Int J Med Microbiol; 2012 Mar; 302(2):96-100. PubMed ID: 22197537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of global patterns and the genetics of fusidic acid resistance.
    Farrell DJ; Castanheira M; Chopra I
    Clin Infect Dis; 2011 Jun; 52 Suppl 7():S487-92. PubMed ID: 21546625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of fusB in Staphylococcus aureus clinical isolates.
    Huang J; Ye M; Ding H; Guo Q; Ding B; Wang M
    J Med Microbiol; 2013 Aug; 62(Pt 8):1199-1203. PubMed ID: 23639984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fusidic acid targets elongation factor G in several stages of translocation on the bacterial ribosome.
    Borg A; Holm M; Shiroyama I; Hauryliuk V; Pavlov M; Sanyal S; Ehrenberg M
    J Biol Chem; 2015 Feb; 290(6):3440-54. PubMed ID: 25451927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of fusidic acid inhibition of RRF- and EF-G-dependent splitting of the bacterial post-termination ribosome.
    Borg A; Pavlov M; Ehrenberg M
    Nucleic Acids Res; 2016 Apr; 44(7):3264-75. PubMed ID: 27001509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Fusidic Acid on the Kinetics of Molecular Motions During EF-G-Induced Translocation on the Ribosome.
    Belardinelli R; Rodnina MV
    Sci Rep; 2017 Sep; 7(1):10536. PubMed ID: 28874811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic basis of resistance to fusidic acid in staphylococci.
    O'Neill AJ; McLaws F; Kahlmeter G; Henriksen AS; Chopra I
    Antimicrob Agents Chemother; 2007 May; 51(5):1737-40. PubMed ID: 17325218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial activity of fusidic acid in Escherichia coli is dependent on the relative levels of ribosome recycling factor and elongation factor G.
    Ayyub SA; Lahry K; Dobriyal D; Mondal S; Varshney U
    FEMS Microbiol Lett; 2018 Jul; 365(13):. PubMed ID: 29846570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural insights into fusidic acid resistance and sensitivity in EF-G.
    Hansson S; Singh R; Gudkov AT; Liljas A; Logan DT
    J Mol Biol; 2005 May; 348(4):939-49. PubMed ID: 15843024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.